We are live on ! Find out more
EDIT icon

Editas Medicine

250 hedge funds and large institutions have $465M invested in Editas Medicine in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 63 increasing their positions, 67 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more capital inflows, than outflows

Capital inflows: $106M | Capital outflows: $55.7M

45% more call options, than puts

Call options by funds: $15.7M | Put options by funds: $10.8M

6% more ownership

Funds ownership: 70.2% → 76.2% (+6%)

6% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 67

6% less funds holding

Funds holding: 266 → 250 (-16)

23% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 53

Holders
250
Holders Change
-16
Holders Change %
-6.02%
% of All Funds
4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
63
Reduced
67
Closed
53
Calls
$15.7M
Puts
$10.8M
Net Calls
+$4.89M
Net Calls Change
-$232K

EDIT Hedge Fund Activity: Q4 2022 in Review

250 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2022, worth a combined $465M — down 21% from $592M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of EDIT and 41 opened new positions — a net loss of 12 holders — while 67 trimmed existing stakes and 63 added.

The largest buyer was State Street, adding an estimated $31.5M. The largest seller was Cubist Systematic Strategies, exiting entirely with an estimated $4.61M sold.

  • 250 institutional investors held Editas Medicine (EDIT) as of Q4 2022, down from 266 in Q3 2022.
  • Funds reported $465M of Editas Medicine stock for Q4 2022, down 21% quarter-over-quarter.
  • 41 funds opened new Editas Medicine positions in Q4 2022 and 53 closed out, a net change of -12 holders.
  • The largest Editas Medicine buyer in Q4 2022 was State Street, an estimated $31.5M added.
  • The largest Editas Medicine seller in Q4 2022 was Cubist Systematic Strategies, an estimated $4.61M sold.

Based on aggregated 13F filings for Q4 2022.